General MedicationsORALStandard

CLINDAMYCIN HYDROCHLORIDE

Standard Dose

EQ 150MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview CLINDAMYCIN HYDROCHLORIDE is listed in Drugs@FDA under application 216957 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 150MG BASE Sponsor GLENMARK PHARMS LTD Submission history Latest submission status date: 2023-03-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLINDAMYCIN HYDROCHLORIDE is listed in Drugs@FDA under application 216957 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 150MG BASE Sponsor GLENMARK PHARMS LTD Submission history Latest submission status date: 2023-03-10 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.